Latest Content

Early Data Demonstrate Ablation May Alleviate Pain From Pancreatic Cancer

November 1st 2024, 1:00pm

By Darlene Dobkowski, MA

Article

In the first 15 patients, radiofrequency ablation was shown to reduce pain scores in most patients with pancreatic cancer.

First Patients Dosed in Three Trials Assessing Dato-DXd-Based Regimens in Lung Cancer

October 31st 2024, 9:00pm

By Darlene Dobkowski, MA

Article

Three phase 3 trials will assess datopotamab deruxtecan-based treatments in patients with nonsquamous non-small cell lung cancer.

Opdivo and Yervoy May Improve Survival for Resected Stage 3/4 Melanoma

October 31st 2024, 7:00pm

By Spencer Feldman

Article

Patients with resected stage 3 or 4 melanoma treated with immune-oncology agents demonstrated significantly higher cure rates compared to those treated with placebo.

A Month Without Pink, Almost

October 31st 2024, 5:00pm

By Felicia Mitchell

Article

Preoccupied with other worries during October, a month full of cancer anniversaries, I reflect on how Pinktober caught up with me.

Inrebic May Reduce Spleen Volume in Myelofibrosis

October 31st 2024, 3:00pm

By Alex Biese

Article

Second-line treatment with Inrebic has been shown to be beneficial for patients with myelofibrosis previously treated with Jakafi.

FDA Warns Against Use of BioZorb Markers

October 31st 2024, 1:00pm

By Alex Biese

Article

The agency is alerting patients and providers to not use the implantable devices, made for soft tissue such as breast tissue.

Connecting With Others Can Benefit the Greater Breast Cancer Community

October 30th 2024, 9:00pm

By Darlene Dobkowski, MA

Video

In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to learn more about how patients with breast cancer can connect with each other.

Self-Advocacy Remains Critical During Breast Cancer

October 30th 2024, 9:00pm

By Darlene Dobkowski, MA

Video

CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center for a webinar to discuss the importance of self-advocacy.

Sharing Experiences to Empower Other Patients With Breast Cancer

October 30th 2024, 9:00pm

By Darlene Dobkowski, MA

Video

In this on-demand webinar series, CURE partnered with Susan G. Komen Foundation and Roswell Park Comprehensive Cancer Center to discuss supporting others with breast cancer.

CAR-T Cell Therapy Receives FDA Designation in Kidney Cancer Subset

October 30th 2024, 7:00pm

By Darlene Dobkowski, MA

Article

Regenerative Medicine Advanced Therapy designation was granted to an investigational CAR-T cell therapy for some patients with renal cell carcinoma.

The Never-Ending Cycle of Cancer: Treatment Versus Long-Term Health

October 30th 2024, 5:00pm

By Debbie Legault

Article

My daughter faced the difficult decision of balancing the potential benefits and risks of cancer treatment, including the long-term heart complications associated with Herceptin.

Current Treatment May Be Superior to Recentin In Ovarian Cancer

October 30th 2024, 3:00pm

By Spencer Feldman

Article

Treatment containing Recentin demonstrated clinical benefits, but it proves worse than the current standard care treatment.

Balancing Decisions Around Breast Cancer Treatment and Fertility, Breastfeeding

October 30th 2024, 1:00pm

By Darlene Dobkowski, MA

Video

An expert discussed how patients with breast cancer, particularly those with a BRCA mutation, should consider future fertility and breastfeeding when making treatment decisions.

First Patients Dosed in Phase 2 Trial of Ropidoxuridine for Glioblastoma

October 29th 2024, 7:00pm

By Alex Biese

Article

A phase 2 clinical trial of a new brain cancer treatment is underway.

FDA Approves Scemblix for Some With Newly Diagnosed Chronic Myeloid Leukemia

October 29th 2024, 6:12pm

By Darlene Dobkowski, MA

Article

Treatment with Scemblix was shown to improve response rates in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.